It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
We disclose herein an unprecedented Pd-catalyzed difluorocarbene transfer reaction, which assembles a series of structurally interesting chiral spiro ketones with generally over 90% ee. Commercially available BrCF2CO2K serves as the difluorocarbene precursor, which is harnessed as a user-friendly and safe carbonyl source in this transformation. Preliminary mechanistic studies exclude the formation of free CO in the reaction process, and importantly, we also find that BrCF2CO2K outcompete gaseous CO and several common CO surrogates in this asymmetric process. The reaction mechanism, including the in-situ progressive release of the difluorocarbene, the rapid migratory insertion of ArPd(II) = CF2 species, and subsequent defluorination hydrolysis by water to introduce the carbonyl group, accounts for the overall high efficiency and uniqueness. This work clearly showcases the advantage and potential of the difluorocarbene in synthesis and supplies a mechanistically distinct route for asymmetric carbonylative cyclization reactions.
Difluorocarbenes are versatile synthetic intermediates, used for both generating fluorinated products as well as modulating organometallic catalytic reaction pathways. Here, the authors introduce a palladium/chiral ligand system that applies the metal–difluorocarbene intermediate toward a carbonylative spirocyclization.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Lian, Zhong 5
; Lin, Shaoquan 6 ; Wang, Shou-Guo 3
; Yin, Qin 1
1 Shenzhen University of Advanced Technology, Shenzhen, P. R. China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649); Chinese Academy of Sciences, Shenzhen Institute of Advanced Technology, Shenzhen, P. R. China (GRID:grid.9227.e) (ISNI:0000000119573309)
2 Shenzhen University of Advanced Technology, Shenzhen, P. R. China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649); Nanchang University, School of Chemistry and Chemical Engineering, Nanchang, P. R. China (GRID:grid.260463.5) (ISNI:0000 0001 2182 8825)
3 Chinese Academy of Sciences, Shenzhen Institute of Advanced Technology, Shenzhen, P. R. China (GRID:grid.9227.e) (ISNI:0000000119573309)
4 Nanchang University, School of Chemistry and Chemical Engineering, Nanchang, P. R. China (GRID:grid.260463.5) (ISNI:0000 0001 2182 8825)
5 Sichuan University, Department of Dermatology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Chengdu, P. R. China (GRID:grid.13291.38) (ISNI:0000 0001 0807 1581)
6 Shenzhen University of Advanced Technology, Shenzhen, P. R. China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649)




